Drugs / Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen
Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00462215 | Apr → Jun 2007 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Whole virion, Vero cell-derived influenza vaccine containing H5N1 HA antigen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00462215 ↗ |
| Modality | Vaccine | “Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)” NCT00462215 ↗ |